The key difference is that it's a daily injection, not weekly
#GLP1 #Diabetes #Type2Diabetes #ObesityTreatment #OralTherapy #EliLilly #Biotech #ClinicalTrials #HealthcareInnovation #Endocrinology #CardiometabolicHealth #WeightLoss #Pharmaceuticals #InvestorInsights #PatientCare #MedTech #LifeSciences #HealthTech #Semaglutide #GLP1 #EliLilly #Wegovy #Zepbound #Ozempic #Mounjaro #NovoNordisk #Sanofi # #Orforglipron #Marshallcapps #FDA #Regulation #Pharma #Healthcare #Biotech To view or add a comment, sign in Recent observational data suggest that liraglutide, semaglutide, and dulaglutide may offer comparable cardiovascular and kidney benefits in people with type 2 diabetes, while also delivering weight loss support
Watch for hiccups that do not stop, and bring them up with your clinician so they can decide if evaluation or a medication change is needed
There are many rasayanas mentioned in the literature of many acharyas
Chien WL, Lee TR, Hung SY, Kang KH, Wu RM, Lee MJ, Fu WM (2013) Increase of oxidative stress by a novel PINK1 mutation, P209A
Whether or not you experience a side effect, how often it occurs and its severity may be different from these studies